Glycol chitosan stabilized nanomedicine of lapatinib and doxorubicin for the management of metastatic breast tumor
Author:
Funder
Science and Engineering Research Council
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
https://link.springer.com/content/pdf/10.1007/s13346-023-01335-6.pdf
Reference51 articles.
1. Jin X, Mu P. Targeting breast cancer metastasis. Breast Cancer : Basic and Clinical Research. 2015;9(Suppl 1):23. https://doi.org/10.4137/BCBCR.S25460.
2. Andreopoulou E, Schweber SJ, Sparano JA, Mcdaid HM. Therapies for triple negative breast cancer. Expert Opin Pharmacother. 2015;16(7):983. https://doi.org/10.1517/14656566.2015.1032246.
3. Hu Q, Sun W, Wang C, Gu Z. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2015. https://doi.org/10.1016/j.addr.2015.10.022.
4. Cianfrocca ME, Rosen ST, Roenn JH, von Rademaker AW, Rubin SD, Friedman RA, Rozario CP, Gradishar WJ. A phase I trial of pegylated liposomal anthracycline and lapatinib (L) combination in the treatment of metastatic breast cancer (MBC): first evaluation of an anthracycline and lapatinib combination in the treatment of MBC. 2007. https://doi.org/10.1200/Jco.2007.25.18_suppl.1079, 25(18_suppl), 1079–1079. https://doi.org/10.1200/JCO.2007.25.18_SUPPL.1079.
5. Stringer-Reasor EM, May JE, Olariu E, Caterinicchia V, Li Y, Chen D, Della Manna DL, Rocque GB, Vaklavas C, Falkson CI, Nabell LM, Acosta EP, Forero-Torres A, Yang ES. An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. Breast Cancer Res. 2021;23(1):1–12. https://doi.org/10.1186/S13058-021-01408-9/TABLES/3.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status;Bioconjugate Chemistry;2024-08-29
2. A Lipophilic Salt Form to Enhance the Lipid Solubility and Certain Biopharmaceutical Properties of Lapatinib;Molecular Pharmaceutics;2024-06-27
3. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives;Drug Discovery Today;2024-01
4. Polyphyllin VII Promotes Apoptosis in Breast Cancer by Inhibiting MAPK/ERK Signaling Pathway through Downregulation of SOS1;The American Journal of Chinese Medicine;2024-01
5. Nanoparticle-mediated diagnosis, treatment, and prevention of breast cancer;Nanoscale Advances;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3